Anthony M. Manning

Anthony M. Manning (board member) discloses dealings in 3 companies, chiefly Momenta Pharmaceuticals Inc, Palatin Technologies Inc and Monte Rosa Therapeutics, Inc. The record holds 79 filings, for trades running from 7 September 2017 to 29 June 2026.

Sales make up the whole of the open-market record (44 sales, €5.9M). Besides market trades, the filings include 12 share grants and 21 option exercises. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 30 June 2026, reports an open-market sale of €202k in Monte Rosa Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.